Neoadjuvant Tyrosine Kinase Inhibitors (TKI) Enable Surgery for Previously Unresectable 15 cm Anaplastic Thyroid Cancer Case Report: Neoadjuvant TKI for Thyroid Cancer
AACE Endocrinology and Diabetes · 2026-03
DOI: 10.1016/j.aed.2026.03.005 ↗Kurz gefasst
Fallbericht in der Zeitschrift AACE Endocrinology and Diabetes, 2026-03. Verfasst von Deandra Kuruppu und 6 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kuruppu, D., Aljiboree, M., Nguyen, J., Milas, M., Nasr, C., Niu, J., & Shellenberger, T. (2026). Neoadjuvant Tyrosine Kinase Inhibitors (TKI) Enable Surgery for Previously Unresectable 15 cm Anaplastic Thyroid Cancer Case Report: Neoadjuvant TKI for Thyroid Cancer. AACE Endocrinology and Diabetes. https://doi.org/10.1016/j.aed.2026.03.005
Vancouver
Kuruppu D, Aljiboree M, Nguyen J, Milas M, Nasr C, Niu J, et al. Neoadjuvant Tyrosine Kinase Inhibitors (TKI) Enable Surgery for Previously Unresectable 15 cm Anaplastic Thyroid Cancer Case Report: Neoadjuvant TKI for Thyroid Cancer. AACE Endocrinology and Diabetes. 2026. doi:10.1016/j.aed.2026.03.005
BibTeX
@article{Kuruppu2026,
author = {Kuruppu, Deandra and Aljiboree, Miassa and Nguyen, Julie and Milas, Mira and Nasr, Christian and Niu, Jiaxin and Shellenberger, Thomas},
title = {Neoadjuvant Tyrosine Kinase Inhibitors (TKI) Enable Surgery for Previously Unresectable 15 cm Anaplastic Thyroid Cancer Case Report: Neoadjuvant TKI for Thyroid Cancer},
journal = {AACE Endocrinology and Diabetes},
year = {2026},
doi = {10.1016/j.aed.2026.03.005}
}
EUVIMED